| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 429,057 | 347,732 | 388,445 | 396,851 | | Cost of Revenue | 150,939 | 99,714 | 101,465 | 102,185 | | | Gross Profit | 278,118 | 248,018 | 286,980 | 294,666 | | | Operating Expenses | | Research Development | 27,256 | 627,148 | 33,855 | 54,162 | | Selling General and Administrative | 142,323 | 104,911 | 99,278 | 111,973 | | Non Recurring | 48,050 | 8,376 | 1,153 | 38,887 | | Others | 53,349 | 29,515 | 29,695 | 31,805 | | | | Total Operating Expenses | 270,978 | 769,950 | 163,981 | 236,827 | | | | Operating Income or Loss | 7,140 | (521,932) | 122,999 | 57,839 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (814) | (3,265) | 7,086 | 9,138 | | Earnings Before Interest And Taxes | 6,326 | (525,197) | 130,085 | 66,977 | | Interest Expense | 23,103 | 2,473 | 1,828 | 1,838 | | Income Before Tax | (16,777) | (527,670) | 128,257 | 65,139 | | Income Tax Expense | (6,055) | 20,797 | 43,507 | 22,118 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (10,722) | (548,467) | 84,750 | 43,021 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (10,722) | (548,467) | 84,750 | 43,021 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($10,722) | ($548,467) | $84,750 | $43,021 |
|
0.45% Nasdaq 
0.20%
Income Statement
